ALFA Filings
Every announcement, straight from the exchange
Every Dr. Lal Pathlabs earnings call announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements
Dr. Lal PathLabs reported strong Q1 FY27 results with 19.1% revenue growth and 27.2% PAT growth. Strategy remains focused on scientific leadership, patient experience, and operational excellence.
Dr. Lal PathLabs reported strong Q4 FY26 results with 16.6% revenue growth. Focus remains on expansion through 1,100+ new collection centers and high-end diagnostic branding.
Dr. Lal PathLabs reported strong Q4 FY26 revenue growth of 16.6% YoY, driven by volume momentum. The company is focusing on digital transformation and expanding into Tier 3+ markets.
Dr. Lal PathLabs delivered steady growth in Q4 FY26, with revenue rising 16.6% YoY to ₹703 cr. Performance was driven by high sample volumes and expansion into Tier 3+ markets.